Page 19 - FPGEE Management Q&A Book

www.pharmacyexam.com Krisman

a. Honesty. III. Conjugated estrogen
b. Confidentiality.
c. Fidelity. a. I only
d. Informed consent. b. I and II only
c. II and III only
102. If the plan member is already enrolled in a d. All
Medicare Choice plan, they cannot enroll in:
106. Which of the following is NOT covered by a
a. Medicare Part A. Medigap policy? [Select ALL That Apply].
b. Medicare Part C.
c. Medigap. a. Hearing aids
d. Medicare Part B. b. Long-term care
c. Medicare Part A deductible
103. Pharmacies experienced significant negative d. Foreign travel emergency
economic issues during the early stages of Part D
because: 107. Which of the following is the principal source
for obtaining data for pharmacoeconomic analyses?
I. Part D plans pay less reimbursement in general
than Medicaid programs for prescriptions for dual I. The Orange Book
eligible beneficiaries. II. Meta-analysis of the literature
III. Retrospective data from electronic claim
II. Part D plans had a longer payment cycle than database
Medicaid programs, creating cash flow problems for
many pharmacies. a. I only
b. I and II only
III. Pharmacies were unable to bill Part D plans for c. II and III only
prescriptions in some circumstances because they d. All
could not locate appropriate billing information for
many beneficiaries. 108. If a bottle of 250 mg of Cephalexin contains
500 mg of Cephalexin, the product should be
a. I only classified as:
b. I and II only
c. II and III only a. Adulterated
d. All b. Misbranded
c. Deteriorated
104. Which of the following pregnancy categories d. Deactivated
shows high risk to the developing fetus?
109. Samples of prescription drugs received by
a. Category A physicians from medical representative can be:
b. Category B
c. Category D a. Sold to a chain pharmacy store.
d. Category X b. Given to patients.
c. Sold to a hospital pharmacy.
105. Which of the following must be dispensed with d. Sold to another physician.
a PPI?
110. In which of the following healthcare settings is
I. Isotretinoin a therapeutic interchange more commonly
II. Isoproterenol practiced?

17